No Cover Image

Journal article 629 views 45 downloads

A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care

Sofia Taverner Orcid Logo, Cindy Eng, Rebecca Watson, Siba George, Amanda Edwards, David M. Williams, Jeffrey Stephens Orcid Logo

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Volume: 16, Issue: 12, Start page: 102658

Swansea University Author: Jeffrey Stephens Orcid Logo

  • DKA associated with SGLT2i Accepted manuscript, complete.pdf

    PDF | Accepted Manuscript

    ©2022 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)

    Download (95.04KB)
Published in: Diabetes and Metabolic Syndrome: Clinical Research and Reviews
ISSN: 1871-4021
Published: Elsevier BV 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa61828
Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: Dapagliflozin; Empagliflozin; Canagliflozin; SGLT2 inhibitor
College: Faculty of Medicine, Health and Life Sciences
Funders: No funding was required for this work.
Issue: 12
Start Page: 102658